MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays
Hui Li(NorthShore University HealthSystem), Maryellen L. Giger(University of Chicago Medical Center), Suzanne D. Conzen(Southwestern Medical Center), Gary J. Whitman(The University of Texas MD Anderson Cancer Center), Erich P. Huang(NorthShore University HealthSystem), Elizabeth J. Sutton(Memorial Sloan Kettering Cancer Center), Karen Drukker(NorthShore University HealthSystem), Elizabeth A. Morris(University of California Davis Medical Center), Charles M. Perou(University of North Carolina at Chapel Hill), Jose Net(NorthShore University HealthSystem), Yuan Ji(Chicago Department of Public Health), Elizabeth S. Burnside(University of Wisconsin–Madison), Marie A. Ganott(NorthShore University HealthSystem), Yitan Zhu(NorthShore University HealthSystem), Katherine A. Hoadley(University of North Carolina at Chapel Hill)
Cited by 468
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
|Cell|2018|2.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
|CA A Cancer Journal for Clinicians|2007|2.6k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k